iiinova — where your digital self keeps evolving

Minyon Avent @minyonavent.bsky.social · 19/09/2025

Very excited that a Sepsis Seminar is part of the MM2025 pre-conference sessions #Sepsis2025 #WorldSepsisDay

Minyon Avent @minyonavent.bsky.social · 22/05/2025

I enjoy being an #InfectiousDiseases pharmacist because I am part of a multidisciplinary team and all the collaborative opportunities that are available. Happy #IDPharmacistsDay

051

Minyon Avent @minyonavent.bsky.social · 21/05/2025

To celebrate #IDPharmacistsDay look out for the videos from AdPha.au pharmacists showcasing their contributions to Innovations in Infectious Diseases @adphaau.bsky.social @nadinehillock.bsky.social @sonkoning.bsky.social @leggwamy.bsky.social @sidpharm.bsky.social

082

Minyon Avent @minyonavent.bsky.social · 21/05/2025

Very excited to be hearing about the ID innovations as ID pharmacists share their stories to celebrate #IDPharmacistsDay. We will be starting early from the ‘land down under’.

020

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 21/02/2025

Surveillance of Gm negative resistance rates in Australia includes all organisms on the WHO list of priority pathogens, & good representation from across Australian states/territories - Jan Bell presenting at #Antimicrobials2025 #ASA2025 #GmNeg

052

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 22/02/2025

Multiple challenges associated with AMR testing of Gm-negative bacteria - may result in over-reporting of resistance rates (e.g cefiderocol) potentially denying patients optimal treatment options, or under-reporting with life-threatening consequences - Prof Christian Giske #Antimicrobials2025 #AMR

041

Reposted by Minyon Avent

Australian Society for Antimicrobials @ausantibiotics.bsky.social · 22/02/2025

@iainabbott.bsky.social #antimicrobials2025 Excellent summary slides of current and future oral antimicrobials for #UTIs and what’s lefts in the case of #MDR UTIs #IDSky #AMSsky

273

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 22/02/2025

Advocating for linezolid TDM to improve patient outcomes 😊#Antimicrobials2025 #ASA2025 #linezolid #TDM @lisaparadiso.bsky.social

032

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 22/02/2025

Highlighting undocumented off-label topical use of rifampicin during surgery in Australian hospitals, and opportunities for AMS #Antimicrobials2025 #ASA2025 #rifampicin #surgery #AntimicrobialStewardship @edraby.bsky.social #MattRawlins

084

Reposted by Minyon Avent

Murray Green @murraybgreen.bsky.social · 20/02/2025

Giske: beware using Cefiderocol discs in MBL strains - many isolates are S by MIC but in ATU (uncertain) on disc, resulting in over-calling of resistance. #antimicrobials2025

023

Reposted by Minyon Avent

Australian Society for Antimicrobials @ausantibiotics.bsky.social · 22/02/2025

Dr Kylie McIntosh Safer Care Victoria providing updates on the Victorian pilot of pharmacist led UTI management, implications on #AMS and the critical need to #upskill #communitypharmacists #antimicrobials2025 #pharmacysymposium #IDsky #AMSsky #UTI

022

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 22/02/2025

Urinary concentrations of antibiotics much more variable bt patients (compared to variability in blood conc). Many variables to consider including fluid intake, variability across a day, other urodynamic factors - Iain Abbott discussing complexity of treating MDR UTIs #Antimicrobials2025 #AMR #UTI

032

Reposted by Minyon Avent

Australian Society for Antimicrobials @ausantibiotics.bsky.social · 22/02/2025

Kicking off the #pharmacysymposium We have @michyong.bsky.social highlighting the use of marabivir in tricky #ID populations #CMV and real world use beyond the clinical trials. (With promising clinical effectiveness) #antiviralstewardship #antimicrobials2025

063

Reposted by Minyon Avent

Australian Society for Antimicrobials @ausantibiotics.bsky.social · 22/02/2025

@cindyclau.bsky.social #linezolid does one dose fit all???? Most likely not! Dr Cindy Lau goes through some scenarios - elderly, renal and hepatic impairment, #DDIs - where dose reductions may be warranted to improve patient care (& reduce toxicities) #antimicrobials2025 #IDsky #amssky

163

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 21/02/2025

Combining NAUSP & NAPS datasets shows that in general restricted antibiotics have lower usage rates and higher appropriateness, but appropriateness of unrestricted antimicrobials should still be targets for AMS - Caroline Chen #Antimicrobials2025 @cazchen.bsky.social #surveillance #AMS

073

Reposted by Minyon Avent

Catherine Berry (she/her) @catherineberry.bsky.social · 21/02/2025

Jan Bell on the APAS data explorer. Looks amazing. shiny.safetyandquality.gov.au/APASDataExpl...

001

Reposted by Minyon Avent

Australian Society for Antimicrobials @ausantibiotics.bsky.social · 21/02/2025

#ASA VP @iainabbott.bsky.social highlighting how to use OrgTRx data for 1 #antibiograms 2 susceptibility trends 3 extraction for patient level data #slicendice to meet your needs #antimicrobials2025 #ASA2025

041

Reposted by Minyon Avent

Sonia Koning @sonkoning.bsky.social · 21/02/2025

Another amazing whirlwind talk from @erinmccreary.bsky.social on the new antifungals featuring Nora 🐶 #antimicrobials2025 #ASA

195

Minyon Avent @minyonavent.bsky.social · 21/02/2025

Utilizing cool technology to repackage an old drug @erinmccreary.bsky.social

010

Reposted by Minyon Avent

Australian Society for Antimicrobials @ausantibiotics.bsky.social · 21/02/2025

@erinmccreary.bsky.social presenting on the new antifungal pipeline with novel patient experiences with them #antimicrobials2025 #IDsky #AMSsky #antifungals #mycology

1133

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 21/02/2025

Inappropriate and unregulated use of combination topical products containing antifungals, steroids and sub-therapeutic doses of antibiotics has resulted in spread of resistant strains of dermatophytes across Indian subcontinent - Dr Sarah Kidd #Antimicrobials2025 #AntifungalResistance #AMR

043

Reposted by Minyon Avent

ACCP ID PRN @accpinfdprn.bsky.social · 20/02/2025

Have you seen the news?! 🥳 The long awaited cUTI guidelines are up for comments! 🤓📚 🔗: www.idsociety.org/practice-gui... Check it out & be sure to get your comments in by March 19, 2025 @ 5pm! #IDSky #PharmSky

idsociety.org

Complicated Urinary Tract Infections

01710

Reposted by Minyon Avent

Robert Jameson @rhjameson.bsky.social · 06/02/2025

Data Hoarders Are Rushing to Save Vanishing US Health Records -A grassroots effort to preserve US government data takes shape -Scientists work into the night to preserve CDC web information www.bloomberg.com/news/article... via @bloomberg.com @jasongale.bsky.social

bloomberg.com

Data Hoarders Are Rushing to Save Vanishing US Health Records

Computer science professor Niema Moshiri was watching TV last Thursday evening when his phone lit up with frantic messages from a virologist in Canada. The warning was urgent: back up the US Centers f...

022

Minyon Avent @minyonavent.bsky.social · 21/02/2025

Congratulations Kas Thursky and the NCAS team. A well deserved award

010

Reposted by Minyon Avent

Sonia Koning @sonkoning.bsky.social · 20/02/2025

Another name change for Candida auris - “Candidozyma” belonging to the family “Metschnikowia” 😵‍💫😵‍💫😵‍💫 #antimicrobials2025 #ASA

075

Reposted by Minyon Avent

Australian Society for Antimicrobials @ausantibiotics.bsky.social · 20/02/2025

The year in clinical microbiology prof Tony Korman giving us a #bluesky shout out and highlighting the exodus of X to Bluesky to stay up to date on #ID and #micro research & connect with other researchers 💙 #antimicrobials2025 #followus

012

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 20/02/2025

In addition to the clinical advantages of switching from IV to oral antibiotics, there are huge savings in nursing time to gain, and therefore economic advantages, as well as engaging nurses in AMS - Nikhil Singh #antimicrobials2025 #ASA2025 #AMS #IVtoOralSwitch

021

Reposted by Minyon Avent

Anita Williams @catanita.bsky.social · 20/02/2025

The drivers of MRSA in remote Australia are linked directly with the social determinants of health and the ongoing impacts of colonisation #AMR #Antimicrobials2025

A presentation slide that has the title "social equity" and has a quote from a community member which says "you need to be healthy, kids need to be healthy. We don't want them to get sick, they're the future, the future of our communities"

042

Reposted by Minyon Avent

Catherine Berry (she/her) @catherineberry.bsky.social · 20/02/2025

@ashabowen.bsky.social on her amazing work to reduce skin infections in indigenous communities. Preventative components strongly driven by community stakeholders. A masterclass in community engagement and values-based research.

133

Reposted by Minyon Avent

National Centre for Antimicrobial Stewardship @ncas.bsky.social · 20/02/2025

Pharmacist Josephine Wen discussing the value of concise targeted auditing tools in conjunction with larger point prevalence audits for AMS programs. @ausantibiotics.bsky.social #ASA2025

063

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 19/02/2025

Why is infectious diseases so fun? Because it’s complicated! - Dr Erin McCreary presenting on precision dosing of antimicrobials in complex patients #antimicrobials2025 #ASA2025

063

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 20/02/2025

Aprox 1 in 2 aboriginal children living in remote Australian settings have impetigo, the highest prevalence in the world. Plus very high MRSA rates. Prof @ashabowen.bsky.social discussing the healthcare consequences of these issues #antimicrobials2025 #ASA2025 #MRSA #AboriginalAustralians #AMR

063

Reposted by Minyon Avent

Nadine Hillock @nadinehillock.bsky.social · 20/02/2025

Next up … the NCAS session! #antimicrobials2025 #ASA2025

021